Atlas Trials

Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease

Clinical trial NCT02833792 · UNKNOWN

Trial details

NCT number
NCT02833792
Sponsor
Stemedica Cell Technologies, Inc.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Dementia
Start date
2016-06-01
Primary completion
2024-07-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.